PRESS RELEASE published on 03/27/2025 at 21:15, 9 months 25 days ago Nanobiotix Announces First Data From the Completed Dose Escalation Part of a Phase 1 Study Evaluating NBTXR3 (JNJ-1900) as a 2L+ Therapy for Patients With Locally Advanced NSCLC Nanobiotix announces first data from the completed dose escalation part of a Phase 1 study evaluating NBTXR3 (JNJ-1900) as a 2L+ therapy for patients with locally advanced NSCLC. The study shows favorable safety and injection feasibility, with promising survival data NSCLC NANOBIOTIX NBTXR3 Phase 1 Study Dose Escalation
PRESS RELEASE published on 03/27/2025 at 21:13, 9 months 25 days ago EQS-Adhoc: Basler AG: Basler publishes audited financial statements for the 2024 financial year, including a forecast for 2025 and a medium-term outlook Basler AG publishes audited financial statements for 2024 with a forecast for 2025 and a medium-term outlook, revealing sales of Euro 183.7 million and EBITDA of Euro 10.0 million Sales Forecast 2024 Basler AG Audited Financial Statements
PRESS RELEASE published on 03/27/2025 at 21:05, 9 months 25 days ago CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE CureVac receives positive validity decision from European Patent Office in litigation against BioNTech SE regarding mRNA patent BioNTech SE CureVac Patent Litigation European Patent Office MRNA Patent
PRESS RELEASE published on 03/27/2025 at 20:07, 9 months 25 days ago EQS-Adhoc: MBB SE proposes 15th consecutive base dividend increase to €1.11 and anniversary dividend of €2.22 MBB SE proposes 15th consecutive base dividend increase to €1.11 and anniversary dividend of €2.22. Total dividend of €3.33 per share. Annual Report 2024 to be published on 31 March 2025 Shareholders Special Dividend Dividend Increase Annual Report MBB SE
PRESS RELEASE published on 03/27/2025 at 20:00, 9 months 25 days ago Amaze Partners with Empact to Unlock $707.9B EU E-Commerce Market for Creators, Eliminating Surprise Fees and Expanding Global Reach Amaze partners with Empact to enhance creator-fan shopping experience in EU. Collaboration tackles high shipping costs and delivers transparent pricing, faster delivery, and VAT compliance Partnership EU Amaze Empact Creator-fan Shopping Experience
PRESS RELEASE published on 03/27/2025 at 19:26, 9 months 25 days ago Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 15,000 'A' ordinary shares as part of its share buyback program on 27/03/2025. Highest price paid: 537.00 GBp, Lowest price: 534.00 GBp London Stock Exchange Share Buyback Program Fuller, Smith & Turner PLC Numis Securities Limited 'A' Ordinary Shares
PRESS RELEASE published on 03/27/2025 at 19:22, 9 months 25 days ago Getlink SE: Successful pricing of a new €600 million senior secured green notes Getlink SE successfully prices new €600 million green senior secured bond issue due 2030 to repay existing bonds due 2025, reinforcing commitment to sustainable finance Sustainable Finance Bond Issue Green Bond Getlink SE Senior Secured
PRESS RELEASE published on 03/27/2025 at 19:12, 9 months 25 days ago Inside Information / News release on accounts, results Advicenne reports successful commercial performance of Sibnayal® in Europe, with total product sales up 9.4% to €4.9m. Major strides in US development with NDA filing expected in Q3 2025 Financial Results Advicenne Commercial Performance Sibnayal US Development
PRESS RELEASE published on 03/27/2025 at 19:05, 9 months 25 days ago Inside Information / News release on accounts, results Claranova reports FY 2024-2025 first-half results with steady revenue around €300m, EBITDA growth of 23%, net income increase to €9.6m, and strategic shift towards software publishing for profitability and debt reduction Financial Results Revenue Debt Reduction Claranova Software Publishing
REGULATED PRESS RELEASE published on 03/27/2025 at 18:40, 9 months 25 days ago The Combined Ordinary and Extraordinary General Meeting of April 17, 2025 Interparfums announces Combined General Meeting on April 17, 2025 at Pavillon d’Armenonville, Paris. Availability of AGM documents and Q1 2025 sales publication Paris Interparfums Combined General Meeting Q1 2025 Sales AGM Documents
Published on 01/21/2026 at 23:30, 2 minutes ago Galway Metals Reports Robust PEA Results with 33% and 61% After Tax IRR, Using both Long Term and Spot Pricing Scenarios, Respectively
Published on 01/21/2026 at 22:45, 47 minutes ago Premier American Uranium Announces Bought Deal Private Placement for Gross Proceeds of C$10 Million
Published on 01/21/2026 at 22:35, 57 minutes ago Sekur Private Data Ltd. Closes Non-Brokered Private Placement
Published on 01/21/2026 at 19:35, 3 hours 57 minutes ago ACCESS Newswire to Present at the Dealflow Discovery Conference in Atlantic City, New Jersey
Published on 01/21/2026 at 14:40, 8 hours 52 minutes ago Electric Metals (USA) Limited Announces Grant of Deferred Share Units
Published on 01/21/2026 at 22:11, 1 hour 20 minutes ago SNP Remains on Growth Trajectory in 2025 with Third Consecutive Record Year
Published on 01/21/2026 at 21:09, 2 hours 23 minutes ago EQS-Adhoc: Deutsche Börse AG: Deutsche Börse AG and Allfunds Group plc reached an agreement on recommended acquisition by Deutsche Börse AG of Allfunds Group plc
Published on 01/21/2026 at 17:47, 5 hours 45 minutes ago CPI PROPERTY GROUP – Sustainable Finance Update
Published on 01/21/2026 at 16:51, 6 hours 40 minutes ago EQS-Adhoc: SNP SE: Revenue and EBIT in Fiscal Year 2025 Better Than Expected
Published on 01/21/2026 at 17:40, 5 hours 52 minutes ago Eiffage wins in consortium the contract to replace the steel bridge over the Kiel Canal in Germany
Published on 01/21/2026 at 08:45, 14 hours 47 minutes ago ENGIE signs a 10-year Biomethane Purchase Agreement with PepsiCo, its first in the United Kingdom
Published on 01/20/2026 at 17:59, 1 day 5 hours ago Statement of transactions in own shares from January 14, 2026 to January 16, 2026
Published on 01/20/2026 at 07:30, 1 day 16 hours ago Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy